The protective effects of coumestrol against amyloid-beta peptide- and lipopolysaccharide-induced toxicity on mice astrocytes

Neurological Research

Volumn 33, Issue 6, 2011, Pages 663-672

  Liu, Man Hai ^a   Tsuang, Fon Yih ^b   Sheu, Shiow Yunn ^a   Sun, Jui Sheng ^a,c   Shih, Chi Ming ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c Hsin Chu General Hospital   (Taiwan)

Author keywords

Amyloid beta peptide; Astrocyts; Coumestrol; Lipopolysaccharide

Indexed keywords

AMYLOID BETA PROTEIN; COUMESTROL; ESTROGEN RECEPTOR BETA; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; IN VITRO STUDY; NEURITIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

AMYLOID BETA-PEPTIDES; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CELLS, CULTURED; COUMESTROL; LIPOPOLYSACCHARIDES; MICE; NEUROPROTECTIVE AGENTS;

EID: 79959718799     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/1743132810Y.0000000029     Document Type: Article

References (41)

1. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998;88:1337-42.
2. Tang M, Zhang J. Prostate apoptosis response-4 involved in the protective effect of salvianolic acid B against amyloid beta peptide-induced damage in PC12 cells. Jpn J Pharmacol 2002;88:422-7.
3. Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW. In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 1991;563:311-4.
4. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002;297:353-6.
5. Li R, Shen Y. Estrogen and brain: synthesis, function and diseases. Front Biosci 2005;10:257-67.
6. Levine AJ, Battista M. Estrogen replacement therapy: effects on the cognitive functioning and clinical course of women with Alzheimer's disease. Arch Clin Neuropsych 2004;19:769-78.
7. Gutierrez-Zepeda A, Santell R, Wu Z, Brown M, Wu Y, Khan I, et al. Soy isoflavone glycitein protects against beta amyloidinduced toxicity and oxidative stress in transgenic Caenorhabditis elegans. BMC Neurosci 2005;6:54.
8. Thal LJ, Thomas RG, Mulnard R, Sano M, Grundman M, Schneider L. Estrogen levels do not correlate with improvement in cognition. Arch Neurol 2003;60:209-12.
9. Chang EC, Frasor J, Komm B, Katzenellenbogen BS. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Endocrinology 2006;147:4831-42.
10. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252-63.
11. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundbury P. A controlled trail of selegiline, alpha-tocopherol, or both as treatment for AD. N Engl J Med 1997;336:1216-22.
12. Holzbeierlein JM, McIntosh J, Thrasher JB. The role of soy phytoestrogens in prostate cancer. Curr Opin Urol 2005;15:17-22.
13. Morale MC, Serra PA, L'episcopo F, Tirolo C, Caniglia S, Testa N et al. Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration. Neuroscience 2006;138: 869-78.
14. Li LN. Water soluble active components of Salvia miltiorrhiza and related plants. J Chin Pharm Sci 1997;6:57-63.
15. Brinton RD. Cellular and molecular mechanisms of estrogen regulation of memory function and neuroprotection against Alzheimer's disease: recent insights and remaining challenges. Learn Mem 2001;8:121-33.
16. McCarthy KD, de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 1980;85:890-902.
17. Tiwari-Woodruff SK, Buznikov AG, Vu TQ, Micevych PE, Chen K, Kornblum HI, et al. OSP/claudin-11 forms a complex with a novel member of the tetraspanin super family and beta1 integrin and regulates proliferation and migration of oligodendrocytes. J Cell Biol 2001;153:295-305.
18. Alonso D, Dorronsoro I, Rubio L, Muñoz P, García-Palomero E, Del Monte M, et al. Donepezil-tacrine hybrid related derivatives as new dual binding site inhibitors of AChE. Bioorg Med Chem 2005;13:6588-97.
19. Giunta S, Galeazzi R, Valli MB, Corder EH, Galeazzi L. Transferrin neutralization of amyloid beta 25-35 cytotoxicity. Clin Chim Acta 2004;350:129-36.
20. Gibbons HM, Dragunow M. Microglia induce neural cell death via a proximity-dependent mechanism involving nitric oxide. Brain Res 2006;1084:1-15.
21. Ling Z, Zhu Y, Tong C, Snyder JA, Lipton JW, Carvey PM. Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally. Exp Neurol 2006;199:499-512.
22. Peterson PK, Hu S, Salak-Johnson J, Molitor TW, Chao CC. Differential production of and migratory response to beta chemokines by human microglia and astrocytes. J Infect Dis 1997;175:478-81.
23. Gandy S. Estrogen and neurodegeneration. Neurochem Res 2003;28:1003-8.
24. Roof RL, Hall ED. Estrogen-related gender difference in survival rate and cortical blood flow after impact-acceleration head injury in rats. J Neurotrauma 2000;17:1155-69.
25. Zec RF, Trivedi MA. Effects of hormone replacement therapy on cognitive aging and dementia risk in postmenopausal women: a review of ongoing large-scale, long-term clinical trials. Climacteric 2002;5:122-34.
26. Kim H, Bang OY, Jung MW, Ha SD, Hong HS, Huh K, et al. Neuroprotective effects of estrogen against beta-amyloid toxicity are mediated by estrogen receptors in cultured neuronal cells. Neurosci Lett 2001;302:58-62.
27. Murphy GM Jr, Yang L, Cordell B. Macrophage colonystimulating factor augments beta-amyloid-induced interleukin-1, interleukin-6, and nitric oxide production by microglial cells. J Biol Chem 1998;273:20967-71.
28. Eriksson G, Zetterstrom M, Cortes Toro V, Bartfai T, Iverfeldt K. Hypersensitive cytokine response to beta-amyloid 25-35 in astroglial cells from IL-1 receptor type I-deficient mice. Int J Mol Med 1998;1:201-6.
29. Patisaul HB, Whitten PL, Young LJ. Regulation of estrogen receptor beta mRNA in the brain: opposite effects of 17beta-estradiol and the phytoestrogen, coumestrol. Mol Brain Res 1999;67:165-71.
30. Jacob DA, Temple JL, Patisaul HB, Young LJ, Rissman EF. Coumestrol antagonizes neuroendocrine actions of estrogen via the estrogen receptor alpha. Exp Biol Med (Maywood) 2001;226:301-6.
31. Stahl S, Chun TY, Gray WG. Phytoestrogens act as estrogen agonists in an estrogen-responsive pituitary cell line. Toxicol Appl Pharmacol 1998;152:41-8.
32. Davis AM, Ellersieck MR, Grimm KM, Rosenfeld CS. The effects of the selective estrogen receptor modulators, methylpiperidino-pyrazole (MPP), and raloxifene in normal and cancerous endometrial cell lines and in the murine uterus. Mol Reprod Dev 2006;73:1034-44.
33. Cuzzocrea S, Bruscoli S, Crisafulli C, Mazzon E, Agostini M, Muià C, et al. Estrogen receptor antagonist fulvestrant (ICI 182780) inhibits the anti-inflammatory effect of glucocorticoids. Mol Pharmacol 2007;71:132-44.
34. Bhargavan B, Gautam AK, Singh D, Kumar A, Chaurasia S, Tyagi AM, et al. Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenic bone forming effect via differential mitogen activated protein kinase (MAPK) signaling. J Cell Biochem 2009;108:388-99.
35. Yamnik RL, Holz MK. mTOR/S6K1 and MAPK/RSK signaling pathways coordinately regulate estrogen receptor alpha serine 167 phosphorylation. FEBS Lett 2010;584:124-8.
36. Matejuk A, Adlard K, Zamora A, Silverman M, Vandenbark AA, Offner H. 17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis. J Neurosci Res 2001;65:529-42.
37. Katzenellenbogen BS, Choi I, Delage-Mourroux R, Ediger TR, Martini PG, Montano M, et al. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology. J Steroid Biochem Mol Biol 2000;74:279-85.
38. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997;277:1508-10.
39. Elliston JF, Fawell SE, Klein-Hitpass L, Tsai SY, Tsai MJ, Parker MG, et al. Mechanism of estrogen receptor dependent transcription in a cell-free system. Mol Cell Biol 1990;10:6607-12.
40. Yu J, Eto M, Akishita M, Okabe T, Ouchi Y. A selective estrogen receptor modulator inhibits TNF-alpha-induced apoptosis by activating ERK1/2 signaling pathway in vascular endothelial cells. Vascul Pharmacol 2009;51:21-8.
41. Hatae J, Takami N, Lin H, Honda A, Inoue R. 17betaestradiol-induced enhancement of estrogen receptor biosynthesis via MAPK pathway in mouse skeletal muscle myoblasts. J Physiol Sci 2009;59:181-90.